Bullish Moving Averages
7
Bearish Moving Averages
9
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
529.60Today’s High
538.0052W low
375.6052W High
615.60Open Price
534.80Prev. Close
530.3000Volume
12264.00Value
6543457.20Fundamentals
Market Cap
3756.50
Price to Earnings
-53.30
Price to Book Value
1.60
Dividend Yield
0.00
PE to Growth
-0.80
Op Revenue TTM
1704.89
Net Profit TTM
-70.47
Cash From Operating Activity
16.69
Return on Equity %
-2.98
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
58.1
Week
50
Month
45.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
533.72
PIVOT
First Resistance
537.83
Second Resistance
542.12
Third Resistance
546.23
First Support
529.43
Second Support
525.32
Third Support
521.03
Relative Strength Index
46.95
Money Flow Index
31.61
MACD
-3.82
MACD Signal
-4.17
Average True Range
18.1
Average Directional Index
10.54
Rate of Change (21)
2.15
Rate of Change (125)
18.42
Commodity Channel Index
-49.4
Williams %R
-54
BETA
1 Month
0.61
3 Month
0.27
1 Year
0.21
3 Year
0.28
PRICE CHANGE ANALYSIS
↑ 0.3%
1 Week
Low
High
522
543.85
↑ 2.15%
1 Month
Low
High
510.2
561
↓ -1.85%
3 Months
Low
High
501
615.65
↑ 19.76%
6 Months
Low
High
440.25
615.65
↑ 39.36%
1 Year
Low
High
375.65
615.65
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 406.28 | 372.37 | 341.41 | 352.49 | 313.85 | 267.38 | 276.42 | 256.63 | 285.94 | 263.38 | 222.31 | |
| Operating Expenses Qtr | 368.65 | 343.11 | 341.14 | 338.36 | 318.80 | 294.11 | 296.77 | 255.67 | 264.37 | 265.19 | 227.42 | |
| Operating Profit Qtr | 30.59 | 19.32 | -7.31 | 8.31 | -8.73 | -42.16 | -31.13 | -10.89 | 12.49 | -16.90 | -10.45 | |
| EBIDT Qtr Cr | -87.99 | 97.28 | 0.27 | 14.13 | -112.58 | -26.73 | -25.37 | 0.96 | 21.57 | -1.81 | -5.11 | |
| Depreciation Qtr | 25.22 | 25.62 | 27.26 | 27.36 | 28.32 | 28.64 | 26.46 | 22.57 | 21.27 | 21.36 | 20.45 | |
| Net Profit Qtr | -114.97 | 69.30 | -30.81 | -15.70 | -143.83 | -57.12 | -75.46 | -23.28 | 17.33 | -23.50 | -21.43 | |
| Basic EPS Qtr | -16.33 | 9.85 | -4.38 | -2.23 | -20.43 | -8.11 | -10.72 | -3.31 | 2.46 | -3.34 | -3.04 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1472.55 | 1114.28 | 984.99 | 1171.34 | 1003.61 | |
| Operating Expenses Annual Cr | 1391.25 | 1165.35 | 986.48 | 1028.51 | 995.05 | |
| Operating Profit Annual | 50.92 | -92.91 | -43.55 | 95.47 | -90.61 | |
| Operating Profit Margin Annual % | 3.46 | -8.34 | -4.42 | 8.15 | -9.03 | |
| Total Expenses Annual Cr | 1507.13 | 1280.70 | 1071.74 | 1105.70 | 1067.42 | |
| EBIDT Annual Cr | 81.31 | -51.07 | -1.49 | 142.84 | 8.56 | |
| EBIDT Annual margin % | 5.52 | -4.58 | -0.15 | 12.19 | 0.85 | |
| Depreciation | 105.46 | 105.98 | 83.19 | 75.89 | 71.09 | |
| PAT Before ExtraOrdinary Items Annual Cr | -92.18 | -299.70 | -55.43 | 54.08 | -56.32 | |
| Net Profit Annual | -92.18 | -299.70 | -55.43 | 54.08 | -56.32 | |
| Basic EPS Annual | -13.09 | -42.57 | -7.87 | 7.68 | -8.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2294.63 | 2384.27 | 2672.04 | 2697.33 | 2647.18 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 81.13 | 113.21 | 139.63 | 50.27 | 29.68 | |
| Total Current Liabilities Annual Cr | 487.94 | 388.66 | 310.42 | 371.45 | 348.27 | |
| Total Capital Plus Liabilities Annual Cr | 2863.70 | 2886.14 | 3122.08 | 3119.06 | 3025.13 | |
| Fixed Assets Annual | 1287.30 | 1383.76 | 1457.30 | 1417.49 | 1159.37 | |
| Total Non Current Assets Annual | 1454.22 | 1589.96 | 1748.12 | 1813.69 | 1520.42 | |
| Total Current Assets Annual | 1409.48 | 1296.18 | 1373.96 | 1305.37 | 1504.71 | |
| Total Assets Annual | 2863.70 | 2886.14 | 3122.08 | 3119.06 | 3025.13 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 248.21 | 294.41 | 311.26 | 521.58 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -41.57 | -117.33 | -158.31 | -32.50 | -41.84 | |
| Cash from Investing Activity Annual | 53.24 | 202.50 | 104.03 | -80.39 | -35.59 | |
| Cash from Financing Annual Activity | -48.06 | -61.76 | 95.80 | -45.19 | -21.02 | |
| Net Cash Flow Annual | - | 23.41 | 41.53 | -158.07 | -98.45 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 325.91 | 338.65 | 379.52 | 383.11 | 375.99 | |
| ROE Annual % | -4.01 | -12.56 | -2.07 | 2.00 | -2.12 | |
| ROCE Annual % | -1.01 | -6.28 | -3.01 | 2.43 | -2.33 | |
| Total Debt to Total Equity Annual | 0.03 | 0.04 | 0.05 | 0.00 | 0.01 | |
| EBDIT Annual Margin % | 5.63 | -4.76 | -0.15 | 12.70 | 0.94 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 437.85 | 445.66 | 421.16 | 431.82 | 407.21 | 318.85 | 338.02 | 317.46 | 384.34 | 325.96 | 293.31 | |
| Operating Expenses Qtr | 406.35 | 396.26 | 406.87 | 395.17 | 385.62 | 345.26 | 347.13 | 310.57 | 301.52 | 311.93 | 284.03 | |
| Operating Profit Qtr | 25.35 | 38.11 | 8.76 | 28.02 | 16.48 | -42.76 | -18.31 | -0.97 | 68.44 | -0.63 | 6.63 | |
| EBIDT Qtr Cr | -94.12 | 117.41 | 14.30 | 36.65 | -11.95 | -26.41 | -14.13 | 6.88 | 82.83 | 14.03 | 9.28 | |
| Depreciation Qtr | 27.16 | 27.86 | 29.45 | 28.77 | 29.68 | 30.78 | 28.43 | 24.55 | 23.30 | 23.31 | 22.43 | |
| Net Profit Qtr | -129.31 | 83.99 | -24.49 | -0.67 | -44.27 | -63.93 | -70.67 | -23.37 | 71.47 | -14.10 | -12.82 | |
| Basic EPS Qtr | -18.37 | 11.93 | -4.38 | -0.09 | -6.28 | -9.08 | -10.04 | -3.32 | 10.15 | -2.01 | -1.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1736.49 | 1381.54 | 1317.34 | 1285.32 | 1195.03 | |
| Operating Expenses Annual Cr | 1604.65 | 1388.58 | 1197.04 | 1144.03 | 1154.53 | |
| Operating Profit Annual | 100.25 | -45.56 | 72.79 | 91.11 | -50.82 | |
| Operating Profit Margin Annual % | 5.77 | -3.30 | 5.53 | 7.09 | -4.25 | |
| Total Expenses Annual Cr | 1740.55 | 1519.33 | 1294.31 | 1233.50 | 1244.05 | |
| EBIDT Annual Cr | 131.84 | -7.04 | 120.30 | 141.30 | 40.49 | |
| EBIDT Annual margin % | 7.59 | -0.51 | 9.13 | 10.99 | 3.39 | |
| Depreciation | 113.24 | 113.44 | 91.17 | 84.36 | 81.67 | |
| PAT Before ExtraOrdinary Items Annual Cr | -70.47 | -163.66 | 34.12 | 34.67 | -61.00 | |
| Net Profit Annual | -70.47 | -202.23 | 33.06 | 34.32 | -60.18 | |
| Basic EPS Annual | -10.01 | -28.72 | 4.70 | 4.88 | -8.55 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2362.42 | 2435.30 | 2618.41 | 2556.83 | 2531.35 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 99.05 | 118.14 | 148.24 | 63.12 | 46.66 | |
| Total Current Liabilities Annual Cr | 707.88 | 639.60 | 552.13 | 505.76 | 566.73 | |
| Total Capital Plus Liabilities Annual Cr | 3169.34 | 3193.05 | 3318.77 | 3125.71 | 3144.74 | |
| Fixed Assets Annual | 1317.14 | 1402.57 | 1482.30 | 1449.91 | 1198.58 | |
| Total Non Current Assets Annual | 1471.84 | 1601.17 | 1670.38 | 1748.40 | 1458.27 | |
| Total Current Assets Annual | 1697.51 | 1591.88 | 1648.39 | 1377.32 | 1686.47 | |
| Total Assets Annual | 3169.34 | 3193.05 | 3318.77 | 3125.71 | 3144.74 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 151.04 | 145.39 | 561.98 | 397.10 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 16.69 | -85.09 | -259.61 | 33.10 | 19.82 | |
| Cash from Investing Activity Annual | 50.40 | 202.81 | 100.12 | -73.56 | -35.91 | |
| Cash from Financing Annual Activity | -106.31 | -81.30 | 191.23 | -121.19 | -62.30 | |
| Net Cash Flow Annual | - | 36.42 | 31.74 | -161.65 | -78.40 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 335.54 | 345.89 | 371.90 | 363.16 | 359.54 | |
| ROE Annual % | -2.98 | -8.30 | 1.26 | 1.34 | -2.37 | |
| ROCE Annual % | 0.75 | -4.71 | 1.05 | 2.17 | -1.59 | |
| Total Debt to Total Equity Annual | 0.09 | 0.12 | 0.13 | 0.04 | 0.07 | |
| EBDIT Annual Margin % | 7.73 | -0.52 | 9.47 | 11.43 | 3.66 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Hdfc Small Cap Fund | 7.97 | 74517868 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Dr. Prakash Amrut Mody | 12.78 | 74517857 | 0 | 0 |
| Anita Prakash Mody | 1.88 | 74517858 | 0 | 0 |
| Suparna Prakash Mody | 1.35 | 74517859 | 0 | 0 |
| Supriya Prakash Mody | 1.35 | 74517860 | 0 | 0 |
| Ipca Laboratories Limited | 52.67 | 74517862 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Hdfc Small Cap Fund | 7.97 | 74517868 |
| Dsp Healthcare Fund | 1.04 | 74517869 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 0.55 | 74517890 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 01, 2022 | 4 | FINAL | - | Equity Share |
| Jul 22, 2021 | 4 | FINAL | - | Equity Share |
| Aug 20, 2020 | 4 | FINAL | - | Equity Share |
| Jul 18, 2019 | 4 | FINAL | - | Equity Share |
| Jul 19, 2018 | 5 | FINAL | - | Equity Share |
| Jul 13, 2017 | 3 | FINAL | - | Equity Share |
| Mar 17, 2016 | 2 | INTERIM | Mar 19, 2016 | Equity Share |
| Jul 02, 2015 | 2 | FINAL | - | Equity Share |
| Jul 03, 2014 | 4 | FINAL | - | Equity Share |
| Jan 23, 2014 | 4 | INTERIM | Jan 24, 2014 | Equity Share |
| Jul 11, 2013 | 4.5 | FINAL | - | Equity Share |
| Sep 13, 2012 | 3 | FINAL | - | Equity Share |
| Jul 14, 2011 | 2.8 | FINAL | - | Equity Share |
| Oct 21, 2010 | 1.2 | INTERIM | Oct 22, 2010 | Equity Share |
| May 14, 2010 | 7 | INTERIM | May 17, 2010 | Equity Share |
| Oct 27, 2009 | 3 | INTERIM | Oct 28, 2009 | Equity Share |
| Jul 09, 2009 | 5 | FINAL | - | Equity Share |
| Oct 29, 2008 | 3 | INTERIM | Oct 31, 2008 | Equity Share |
| Jul 10, 2008 | 5 | FINAL | - | Equity Share |
| Mar 16, 2007 | 5 | INTERIM | Mar 20, 2007 | Equity Share |
| Jul 13, 2006 | 5 | FINAL | - | Equity Share |
| Jul 14, 2005 | 3.5 | FINAL | - | Equity Share |
| Jul 13, 2004 | 3 | FINAL | - | Equity Share |
| Aug 01, 2003 | 8 | FINAL | - | Equity Share |
| Jun 20, 2002 | 8 | FINAL | - | Equity Share |
| Aug 17, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Oct 21, 2010 | 5:2 | 2010-10-22 |
| Mar 16, 2004 | 10:5 | 2004-03-24 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 22, 2024 | Audited Results | - |
| Feb 05, 2024 | Quarterly Results | - |
| Nov 01, 2023 | Quarterly Results | - |
| Jul 14, 2023 | Quarterly Results | - |
| May 23, 2023 | Audited Results | - |
| Feb 06, 2023 | Quarterly Results | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 09, 2022 | Quarterly Results | - |
| May 27, 2022 | Audited Results & Final Dividend | - |
| Jan 29, 2022 | Quarterly Results | - |
| Nov 02, 2021 | Quarterly Results | - |
| Jul 31, 2021 | Quarterly Results | - |
| May 29, 2021 | Audited Results & Final Dividend | - |
| Jan 30, 2021 | Quarterly Results | - |
| Oct 31, 2020 | Quarterly Results | - |
| Aug 04, 2020 | Quarterly Results | - |
| Jun 19, 2020 | Audited Results & Dividend | - |
| Feb 03, 2020 | Quarterly Results | - |
| Nov 02, 2019 | Quarterly Results | - |
| Jul 27, 2019 | Quarterly Results | - |
| May 24, 2019 | Audited Results | - |
| Feb 01, 2019 | Quarterly Results | - |
| Oct 30, 2018 | Quarterly Results | - |
| Jul 28, 2018 | Quarterly Results | - |
| May 29, 2018 | Audited Results & Dividend | - |
| Feb 05, 2018 | Con. Quarterly Results & Buy Back | - |
| Jan 08, 2018 | Quarterly Results & Buy Back of Shares | - |
| Nov 03, 2017 | Quarterly Results | - |
| Aug 09, 2017 | Quarterly Results | - |
| May 30, 2017 | Audited Results & Final Dividend | - |
| Apr 01, 2017 | Others | Allotment of 25500 Equity Shares under ESOP 2008. |
| Jan 21, 2017 | Quarterly Results | - |
| Oct 21, 2016 | Quarterly Results | - |
| Jul 23, 2016 | Quarterly Results | - |
| May 20, 2016 | Audited Results & Final Dividend | Has allotted 15, 000 Equity shares having a face value of Rs. 2/- each pursuant to exercise of options by eligible employee under the Employees Stock Option Scheme 2008. |
| Mar 09, 2016 | Interim Dividend | - |
| Jan 23, 2016 | Quarterly Results | Allotted 17025 Equity Shares having a face value of Rs. 2/- each pursuant to exercise of options by eligible employees under the Employees Stock Option Scheme 2008. |
| Oct 17, 2015 | Quarterly Results | - |
| Jul 11, 2015 | Quarterly Results | - |
| May 09, 2015 | Audited Results & Final Dividend | - |
| Jan 17, 2015 | Quarterly Results | - |
| Oct 18, 2014 | Employees Stock Option Plan | - |
| Jul 12, 2014 | Quarterly Results | - |
| May 10, 2014 | Audited Results & Final Dividend | - |
| Jan 18, 2014 | Quarterly Results & Interim Dividend | - |
| Oct 19, 2013 | Quarterly Results | - |
| Jul 19, 2013 | Quarterly Results | - |
| May 11, 2013 | Audited Results & Dividend | - |
| Jan 18, 2013 | Quarterly Results | - |
| Oct 20, 2012 | Quarterly Results | - |
| Aug 11, 2012 | Audited, Quarterly Results & Dividend | For the year ended 31st March, 2012 & for the quarter ended 30th June, 2012. |
| May 12, 2012 | Quarterly Results | - |
| Jan 21, 2012 | Quarterly Results & ESOP | The Board has allotted & issued 2,500 Equity Shares of Rs. 2/- each pursuant to the exercise of the stock options by the eligible Employees under the ESOS - 2008 of the Company. |
| Oct 22, 2011 | Quarterly Results | - |
| Jul 28, 2011 | Quarterly Results | - |
| Jun 24, 2011 | Employees Stock Option Plan | The Board allotted and issued 48,376 Equity Shares of Rs. 2/- each, pursuant to the exercise of the stock options by eligible employees under the Employee Stock Option Scheme - 2008 of the Company. |
| May 14, 2011 | Audited Results, F.Dividend & Others | To consider the valuation report, exchange ratio and the Scheme of Arrangement between the following Companies and Unichem Laboratories Limited. |
| Apr 16, 2011 | To approve Annual operating plans | inter alia, to consider and approve Annual operating plans and budget of the Company for the financial year 2011-12. |
| Jan 15, 2011 | Quarterly Results | - |
| Oct 16, 2010 | Quarterly Results & Interim Dividend | - |
| Sep 16, 2010 | Allotment of Equity Shares | The Board has allotted 400 Equity Shares of Rs. 5/- under Employees Stock Option Scheme - 2008. |
| Jul 22, 2010 | Quarterly Results, Stock split & ESOP | To sub-divide the NV of the Equity Shares of the Company from Rs. 5/- each to the NV of Rs. 2/- each & to issue 800 Equity Shares of Rs. 5/- each under the Employee Stock Option Scheme-2004 of the Co. |
| May 10, 2010 | Qtrly Results, 2nd Intm Dividend & ESOP | To issue of 2,800 Equity Shares of Rs. 5/- each, pursuant to the exercise of the stock options by the eligible Employees under the Employee Stock Option Scheme-2004 of the Company. |
| Jan 19, 2010 | Quarterly Results & ESOP | The Board has allotted and issued 1,900 Equity Shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Co. |
| Oct 22, 2009 | Interim Dividend | - |
| Jul 22, 2009 | Quarterly Results | - |
| Jun 25, 2009 | Allotment of Equity Shares | To allot & issue 4,500 equity shares of Rs 5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Company. |
| May 21, 2009 | Audited Results, F. Dividend & ESOP | To issue of 1,700 equity shares of Rs 5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Company. |
| Mar 26, 2009 | Allotment of Equity Shares | To grant 50,000 equity shares to Independent Directors of the Co. in terms of its ESOS - 2008 & grantee will have right to apply & get allotted 1 equity share at an exercise price of Rs 115/-. |
| Jan 22, 2009 | Quarterly Results & Others | To issue 6100 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees / legal heirs under the Employee Stock Option Scheme - 2004 of the Company". |
| Oct 23, 2008 | Quarterly Results & Interim Dividend | - |
| Jul 17, 2008 | Quarterly Results & Others | To issue 1,800 equity shares of Rs 5/ each pursuant to the exercise of the stock options by the eligible employees / legal heirs under the Employee Stock Option Scheme - 2004 of the Company. |
| May 12, 2008 | Audited, Quarterly Results & Dividend | - |
| Jan 31, 2008 | Quarterly Results | - |
| Oct 18, 2007 | Quarterly Results | - |
| Jul 19, 2007 | Quarterly Results | - |
| May 17, 2007 | Audited Results & Dividend | - |
| Mar 13, 2007 | Interim Dividend | - |
| Jan 18, 2007 | Quarterly Results | - |
| Oct 18, 2006 | Quarterly Results | - |
| May 18, 2006 | Accounts & Dividend | - |
| Jan 18, 2006 | Quarterly Results | - |
| Jan 10, 2006 | Preferential Issue of shares | - |
| Nov 15, 2005 | Allotment of Stock Options | Has allotted and issued 7,000 equity shares of Rs 5/- each pursuant to the exercise of the stock options by the eligible employees / legal heirs under the Employee Stock Option Scheme - 2004 (ESOS). |
| Oct 17, 2005 | Quarterly Results | - |
| Jul 16, 2005 | Quarterly Results | - |
| Jun 03, 2005 | Dividend & Accounts | - |
| Jan 20, 2005 | Quarterly Results | - |
| Oct 15, 2004 | Quarterly Results | - |
| Jul 22, 2004 | Quarterly Results | - |
| May 20, 2004 | Dividend & Accounts | - |
| Mar 27, 2004 | Others | To cosider the allotment of bonus Equity shares. |
| Feb 28, 2004 | Others | To fix the record date for the purpose of sub-division of shares and issue of Bonus shares. |
| Jan 30, 2004 | Bonus issue & Sub Division of shares | (i) setting up of a wholly-owned subsidiary in U.S.A. (ii) Offering Stock options to employees. |
| Jan 23, 2004 | Quarterly Results | - |
| Oct 16, 2003 | Quarterly Results | - |
| Jul 28, 2003 | Quarterly Results | - |
| Jun 14, 2003 | Dividend | - |
| Jan 30, 2003 | Quarterly Results | - |
| Oct 19, 2002 | Quarterly Results | - |
| Jul 20, 2002 | Quarterly Results | - |
| May 15, 2002 | Accounts & Dividend | - |
| Mar 04, 2002 | Interim Dividend | - |
| Jan 31, 2002 | Quarterly Results | - |
| Oct 20, 2001 | Half Yearly Results & Quarterly Results | - |
| Jul 28, 2001 | Dividend & Quarterly Results | - |
| Apr 19, 2001 | Accounts | - |
| Jan 24, 2001 | Quarterly Results | - |
| Oct 21, 2000 | Quarterly Results | - |
| Jul 29, 2000 | Accounts & Quarterly Results | - |
| Apr 29, 2000 | Quarterly Results | - |
| Mar 16, 2000 | Interim dividend | - |
| Feb 05, 2000 | Bonus issue | - |
| Jan 19, 2000 | Quarterly Results | - |
| Oct 23, 1999 | Quarterly Results | - |
| Jul 31, 1999 | Quarterly Results | - |
| Jun 10, 1999 | Accounts | - |
| Jan 23, 1999 | Quarterly Results | - |
| Oct 31, 1998 | Quarterly Results | - |
| Jul 30, 1998 | Quarterly Results | - |
| Jun 27, 1998 | Accounts | - |
| Nov 29, 1997 | Half Yearly Results | - |
| Aug 26, 1997 | Accounts | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Mar 16, 2004 | 1:1 | 2004-03-24 |
| Apr 03, 2000 | 1:1 | 2000-04-20 |
01 Jul 2024
UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)- Newspaper Publication.
01 Jul 2024
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate
28 Jun 2024
UNICHEM LABORATORIES LTD. - 506690 - Shareholder Meeting - AGM On August 8, 2024
Shareholder Meeting - AGM on August 8, 2024
27 Jun 2024
UNICHEM LABORATORIES LTD. - 506690 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Pl. find attached herewith intimation u/r. 30 of LODR.
26 Jun 2024
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg 39(3) - Details of Loss of Share certificate.
25 Jun 2024
UNICHEM LABORATORIES LTD. - 506690 - Closure of Trading Window
Intimation - Closure of Trading Window
17 Jun 2024
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pl. find attach herewith an intimation w.r.t. loss of share certificate.
17 Jun 2024
UNICHEM LABORATORIES LTD. - 506690 - Resignation Of An Internal Auditor
Pl. find attach herewith an intimation w.r.t. the resignation of an internal auditor.
17 Jun 2024
UNICHEM LABORATORIES LTD. - 506690 - Resignation Of An Internal Auditor
Pl. find attach herewith an intimation w.r.t. the resignation of an internal auditor.
12 Jun 2024
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance under Reg. 39(3) - Details of issuance of Letter of Confirmation.
